GlassScriptPhysician profile
Lisa E Mcguire
NPI 1235216086
$1,207.82
in general payments reported to CMS, 2019-2025
19 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $134 · 2021: $272 · 2022: $21.21 · 2023: $120 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $220 · Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $219.96 |
| Food and Beverage | $166.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $308.50 | 2019-2025 | Freestyle Copilot, Freestyle Libre 3, Freestyle Libre |
| Medtronic Minimed, INC. | $168.84 | 2019-2020 | |
| Amgen INC. | $133.78 | 2019-2021 | |
| Insulet Corporation | $111.30 | 2021-2023 | Omnipod |
| Dexcom, INC. | $84.62 | 2019-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $61.40 | 2019-2021 | |
| Horizon Therapeutics Plc | $42.73 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $42.70 | 2021-2022 | |
| Medtronic, INC. | $42.69 | 2023-2025 | Minimed 780g |
| Janssen Pharmaceuticals, INC | $37.33 | 2019-2020 | |
| Novo Nordisk INC | $33.27 | 2019 | |
| Abbvie INC. | $26.32 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $24.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.61 | 2019 | |
| Ucb, INC. | $15.62 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.90 | 2019 | |
| Radius Health, INC. | $13.66 | 2021 | |
| Merck Sharp & Dohme LLC | $12.60 | 2019 | |
| Gilead Sciences, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Mcguire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.